In Vitro Diagnostics Market Size – By Product Type (Reagents and Kits, Instruments and Software and Services), By Technology (Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation and Hemostasis, Urinalysis, Point-of-Care Testing (POCT), and Others), By Application (Infectious Diseases, Diabetes, Oncology/Cancer, Cardiology, Autoimmune Diseases, Nephrology, Drug Testing, and Others), By End-user (Hospitals, Laboratories, Academic & Research Institutes, Point-of-Care Testing Centers, Home Care Settings and Others) & Region – Global Forecasts 2024 - 2034
- PUBLISHED ON
- 2024-10-16
- NO OF PAGES
- 330
- CATEGORY
- Healthcare & Life Sciences
Market Overview
The In Vitro Diagnostics market report is predicted to develop at a compound annual growth rate (CAGR) of 4.3% from 2024 to 2034, when global In Vitro Diagnostics market forecast size is projected to reach USD 125.43 Billion in 2034, based on an average growth pattern. The global In Vitro Diagnostics market revenue is estimated to reach a value of USD 75.72 Billion in 2024.
SOURCE: We Market Research
The Global In
Vitro Diagnostics (IVD) market analysis refers to the sector of medical devices
and equipment used to perform diagnostic tests on samples taken from the human
body, such as blood, urine, tissue, or other bodily fluids. These tests are
conducted outside the human body, in laboratories or at the point of care, and
are designed to detect diseases, conditions, infections, and overall health
status.
The purpose of
IVDs is to aid in diagnosing medical conditions, monitoring disease
progression, predicting treatment response, and guiding therapeutic decisions.
The market encompasses a wide range of products, including reagents,
instruments, software, and services, utilizing various technologies like
immunoassays, molecular diagnostics, clinical chemistry, microbiology,
hematology, and more. IVDs are used across multiple applications, including
infectious diseases, cancer, cardiology, autoimmune disorders, and more, in
diverse settings such as hospitals, clinical laboratories, research
institutions, and home healthcare. The IVD market plays a critical role in
healthcare by enabling early diagnosis, disease prevention, and personalized
treatment strategies, thus improving patient outcomes and reducing healthcare
costs.
Market Scope
|
Report Attributes |
Description |
|
Market Size in 2024 |
USD 75.72 Billion |
|
Market
Forecast in 2034 |
USD 125.43 Billion |
|
CAGR % 2024-2034 |
4.3% |
|
Base
Year |
2023 |
|
Historic Data |
2016-2022 |
|
Forecast
Period |
2024-2034 |
|
Report USP
|
Production,
Consumption, company share, company heatmap, company production capacity,
growth factors and more |
|
Segments
Covered |
By Product
Type, By Technology, By Application, By End-user and By Region |
|
Regional Scope |
North America,
Europe, APAC, South America and Middle East and Africa |
|
Country
Scope |
U.S.; Canada;
U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia;
China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico;
Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria |
Market: Dynamics & Restrains
Global In Vitro Diagnostics Market Opportunity:
We Market
Research: Dashboard
Our marketing
platform offers a comprehensive dashboard that provides clients with valuable
insights into global In Vitro Diagnostics market trends over the years.
Included below is a sample image of our dashboard, and specific PDF logins will
be furnished to grant access to this insightful tool.